Haemonetics (HAE) earnings

Earnings (net income) · fiscal 2026
$97.31M

Haemonetics (HAE) reported net income of $97.31M in fiscal 2026 (the year ended March 31, 2026). That is 42.0% lower than the $167.68M of fiscal 2025. Figures as of 18 Nov 2026, 04:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2026
$97.31M
Change on fiscal 2025
−42.0%
Growth, 5 years
+4.1% a year
Highest on record
$167.68Mfiscal 2025
Lowest on record
-$55.58Mfiscal 2016
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Haemonetics earnings, in more detail

Over the five fiscal years to 2026 net income grew at a compound 4.1% a year. Across the 18 fiscal years on record (2009–2026), the highest was $167.68M in fiscal 2025 and the lowest -$55.58M in fiscal 2016.

History · 18 fiscal years

Earnings (net income) by fiscal year

Haemonetics earnings, year by year

Haemonetics (HAE) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2026$97.31M 42.0% down
2025$167.68M 42.6% up
2024$117.56M 1.9% up
2023$115.40M 166.1% up
2022$43.38M 45.4% down
2021$79.47M 3.8% up
2020$76.53M 39.1% up
2019$55.02M 20.7% up
2018$45.57M—
2017-$26.27M—
2016-$55.58M 428.9% down
2015$16.90M 51.9% down
2014$35.15M 9.4% down
2013$38.80M 42.0% down
2012$66.89M 16.4% down
2011$79.98M 37.0% up
2010$58.37M 1.6% down
2009$59.30M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Haemonetics and comparable companies
CompanyEarnings (net income)Fiscal year
Hims & Hers Health HIMS$128.37M2025
PTC Therapeutics PTCT$682.64M2025
Haemonetics HAE$97.31M2026
Erasca ERAS-$124.55M2025
Concentra Group Holdings Parent CON$166.42M2025
Merit Medical Systems MMSI$128.49M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HAE

Haemonetics, figure by figure

Haemonetics (HAE) overview: price, valuation and scorecardAll health care companies by market value

Haemonetics earnings: questions and answers

What is Haemonetics's net income?

Haemonetics (HAE) reported net income of $97.31M in fiscal 2026 (the year ended March 31, 2026). That is 42.0% lower than the $167.68M of fiscal 2025.

What is the growth rate of Haemonetics's net income?

Over the five fiscal years to 2026 net income grew at a compound 4.1% a year.

What are the highest and lowest net income figures on record for Haemonetics?

Across the 18 fiscal years on record (2009–2026), the highest was $167.68M in fiscal 2025 and the lowest -$55.58M in fiscal 2016.

How is Haemonetics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Haemonetics (HAE) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/HAE/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.